EUCTR2009-016482-28-DE进行中（未招募）1 期
SUNIMUD - Sunphenon EGCg (Epigallocatechin-Gallate) in Duchenne Muscular Dystrophy - SUNIMUD
Charite Universitätsmedizin Berlin0 个研究点目标入组 40 人开始时间: 2010年3月15日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Duchenne Muscular Dystrophy
- •Male patients > 4 years
- •ability to walk without help (a minimum of 75 meters)
- •maximum 2 cups of black tea, no consumption of grean tee, no consumption of greater amounts of grapefriut juice
- •Informed consent of parents
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 40
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •serious other organic disease
- •known intolerance of Sunphenon
- •massiv and protracted exposure to sun
- •participation in other interventional clinical trials on pharmaceuticals or medical devices during the study or 3 months before
- •futher primary psychiatric/neurologic disorders
- •known allergy against Sunphenon EGCg or additives of the study medication or placebo capsules
- •longterm intake of liver toxic medication
研究者
相似试验
进行中（未招募）
1 期
Sunphenon EGCg (Epigallocatechin-Gallat) in the early stage of Alzheimer´s Disease - SUN-AKEUCTR2009-009656-20-DECharite Universitaetsmedizin Berlin50
进行中（未招募）
不适用
Sunphenon (Epigallocatechin-Gallate) in relapsing-remitting multiple sclerosis - Sunphenon in RR-MSrelapsing-remitting multiple sclerosisICD classification: G35.1EUCTR2006-006323-39-DECharité-Universitätsmedizin Berlin100
已完成
1 期
Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)Relapsing-remitting Multiple SclerosisNCT00525668Charite University, Berlin, Germany120
已完成
2 期
Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s DiseaseAlzheimer's DiseaseNCT00951834Charite University, Berlin, Germany21
已完成
2 期
Sunphenon in Progressive Forms of Multiple SclerosisMultiple SclerosisNCT00799890Friedemann Paul61